Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated October 30, 2015, titled, “Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg……
| Subscribe To Our Free Newsletter |
